Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

Tell us a bit about your clinical programs and how they are different from the existing therapies. Addex is a…

After beating COVID blues, what awaits McDonald’s (MCD) in the new year?

For the restaurant industry, things have not changed much since being hit hard by the pandemic nearly two years ago…

Constellation Brands (STZ): Mexico investments, Coca-Cola agreement to help portfolio growth

Shares of Constellation Brands (NYSE: STZ) stayed in red territory despite the company reporting better-than-expected results for the third quarter…

Constellation Brands (NYSE: STZ) Q3 2022 earnings: Infographic

Constellation Brands (NYSE: STZ), the largest beer producer in the U.S, reported third-quarter 2022 earnings results today.  The net sales…

IPO News: TPG Partners eyes $9.5-bln valuation in mega listing. What to look for

Continuing the hectic IPO activity seen last year, the market is bracing for some of the keenly awaited initial public…

AAPL Stock: What does the $3-trillion valuation mean for Apple?

Apple Inc. (NASDAQ: AAPL) has probably more achievements to its credit than any other company, and the gadget giant added…

IPO news: Here are a few points to note as Amylyx Pharmaceuticals goes public this week

There are quite a few pharmaceutical companies lined up to make their market debut this week. Among these is Amylyx…

IPO News: Reborn Coffee set to go public. Here’s all you need to know

After a year of record activity, the IPO market seems to be warming up for a busy 2022. The upcoming…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering…

IPO news: What to look for when Vigil Neuroscience goes public this week

As the first week of the new year slowly unfolds, it appears the pharmaceutical industry is taking the front seat…